Skip to main content

Table 1 Checklist for clinical data collection and follow-up plan of enrolled patients

From: The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study

 

Screening stage

Treatment period (one day to three months after enrollment)

Evaluation period (once every three months for 24 months)

Informed consent

X

  

Demographic statistics

X

  

History of present illness and treatment

X

  

Symptoms and vital signs

X

X

X

Inclusion/exclusion criteria

X

  

Blood routine

X

X

X

Blood biochemical test

X

X

X

G test of peripheral blood

X

X

X

GM test peripheral blood

X

X

X

CD4/CD8

X

X

X

IgA, IgG, IgM

X

X

X

HCG of peripheral blood or urine

X

  

Noninvasive oxygen saturation

X

  

Chest CT

X

X

X

Electrocardiograph

X

X

X

Fungal smear and culture

X

X

X

Basic drugs and combined drugs

X

X

X

Distribution of research drugs

X

  

Recall of research drug

 

X

X

Evaluation of adverse events

X

X

X

Schedule of next visit

 

X

X

Compliance evaluation

 

X

X

effectiveness evaluation

 

X

X

SGRQ score

X

X

X

Evaluation of microbiological efficacy

 

X

X

Survival

 

X

X

  1. HCG, human chorionic gonadotropin; Ig immune globulin; SGRQ, St. George’s Respiratory Questionnaire